If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
558.50    -0.50 (-0.09%)
Bid:
558.50
Ask:
559.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Holding(s) in Company

18 May 2017 14:40

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii Tate & Lyle PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments X
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to thenotification obligation: iii Deutsche Bank AG
4. Full name of shareholder(s)(if different from 3.):iv Deutsche Bank AG, London Branch
5. Date of the transaction and date onwhich the threshold is crossed orreached: v 15/05/2017
6. Date on which issuer notified: 17/05/2017
7. Threshold(s) that is/are crossed orreached: vi, vii Below 5%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction Resulting situation after the triggering transaction
NumberofShares NumberofVotingRights Numberof shares Number of votingrights % of voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB0008754136 13,683,645 13,683,645 Below Notifiable Threshold Below Notifiable Threshold 0 Below Notifiable Threshold 0
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financialinstrument Expirationdate xiii Exercise/ Conversion Period xiv Number of votingrights that may beacquired if theinstrument isexercised/ converted. % of votingrights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financialinstrument Exercise price Expiration date xvii Exercise/Conversion period xviii Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
Below Notifiable Threshold Below Notifiable Threshold
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will ceaseto hold:
12. Date on which proxy holder will cease to holdvoting rights:
13. Additional information:
14. Contact name: Osamede Aigbe
15. Contact telephone number: 0207 541 8440
Listed Company Contact name: Claire-Marie O’Grady

Company Secretary

020 7257 2100

View source version on businesswire.com: http://www.businesswire.com/news/home/20170518005733/en/

Copyright Business Wire 2017

Date   Source Headline
6th Jul 20265:01 pmGNWForm 8.3 - TATE & LYLE PLC
6th Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
6th Jul 20262:48 pmRNSForm 8.3 - Tate & Lyle plc
6th Jul 20262:04 pmRNSForm 8.3 - Tate & Lyle plc
6th Jul 20261:27 pmRNSForm 8.5 (EPT/RI)-Amend-TATE & LYLE PLC
6th Jul 202612:46 pmRNSForm 8.3 TATE & LYLE PLC
6th Jul 202612:36 pmRNSForm 8.3 Tate & Lyle plc
6th Jul 202611:55 amRNSForm 8.3 - Tate & Lyle plc
6th Jul 202611:36 amRNSForm 8.5 - Tate & Lyle Plc
6th Jul 202611:33 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
6th Jul 202610:50 amRNS20260703_TATE & LYLE_8.5 EPT RI_UK_MLI
6th Jul 202610:48 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
6th Jul 202610:38 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
6th Jul 20269:05 amRNSForm 8.5 (EPT/RI)
3rd Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jul 20262:59 pmRNSForm 8.3 - Tate & Lyle PLC
3rd Jul 20262:44 pmRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
3rd Jul 20262:39 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jul 20262:20 pmRNSForm 8.3 Tate & Lyle plc
3rd Jul 202611:43 amRNSForm 8.5 (EPT/RI) - TATE LYLE PLC
3rd Jul 202611:34 amRNSForm 8.5 (EPT/RI) - Tate & Lyle
3rd Jul 202611:28 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
3rd Jul 202611:23 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
3rd Jul 202611:20 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jul 202611:09 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
3rd Jul 202611:00 amRNSForm 8.3 TATE & LYLE PLC
3rd Jul 202610:27 amRNSForm 8.3 - Tate & Lyle plc
3rd Jul 20269:19 amRNSForm 8.5 (EPT/RI) - Tate & Lyle PLC
3rd Jul 20267:00 amRNSScheme of Arrangement
3rd Jul 20267:00 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc Amend
2nd Jul 20263:30 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 20263:00 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202612:36 pmRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202612:27 pmRNSForm 8.3 TATE & LYLE PLC
2nd Jul 202611:59 amRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202611:31 amRNSForm 8.3 - Tate & Lyle plc
2nd Jul 202611:31 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
2nd Jul 202611:27 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jul 202611:24 amRNSForm 8.3 Tate & Lyle Plc
2nd Jul 202611:23 amRNS20260701_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
2nd Jul 202611:23 amRNS20260701_TATE & LYLE_8.5 EPT RI_UK_MLI
2nd Jul 202611:19 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
2nd Jul 202611:18 amRNSForm 8.5 (EPT/RI)-TATE & LYLE PLC
2nd Jul 20269:35 amRNSForm 8.5 (EPT/RI)-Amendment
2nd Jul 20269:34 amRNSForm 8.5 (EPT/RI)
1st Jul 20263:25 pmRNSForm 8.3 TATE & LYLE PLC
1st Jul 20263:18 pmRNSForm 8.3 TATE & LYLE PLC
1st Jul 20263:14 pmRNSForm 8.3 - Tate & Lyle PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.